Please try another search
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company’s TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Name | Age | Since | Title |
---|---|---|---|
William F. Doyle | 59 | 2004 | Executive Chairman |
William Anthony Vernon | 66 | 2006 | Lead Independent Director |
Kinyip Gabriel Leung | 60 | 2011 | Independent Director |
Jeryl Lynn Hilleman | 64 | 2018 | Independent Director |
Martin J. Madden | 61 | 2017 | Independent Director |
David T. Hung | 64 | 2018 | Independent Director |
Timothy John Scannell | 57 | 2021 | Independent Director |
Allyson J. Ocean | 51 | 2023 | Independent Director |
Kristin Stafford | 41 | 2023 | Independent Director |
Asaf Danziger | 58 | 2002 | CEO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review